| Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis (NCT05575193) | National Taipei University of Nursing and Health Sciences | 2021-03-15 |
| A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. (NCT04711603) | Kissei Pharmaceutical Co., Ltd. | 2021-01-16 |
| The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus (NCT04650750) | Chang Gung Memorial Hospital | 2020-12-01 |
| A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet (NCT04728984) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2020-09-07 |
| A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis (NCT04470154) | Haisco Pharmaceutical Group Co., Ltd. | 2020-08-10 |
| AST-120 in Hemodialysis Patients With Uremic Pruritus (NCT04639674) | Conmed Pharmaceutical & Bio-Medical Corporation | 2020-07-02 |
| Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients (NCT04393675) | Lumosa Therapeutics Co., Ltd. | 2020-05-14 |
| CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (NCT03998163) | Cara Therapeutics, Inc. | 2019-05-06 |
| A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. (NCT03802617) | Kissei Pharmaceutical Co., Ltd. | 2019-02-01 |
| CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (NCT03636269) | Cara Therapeutics, Inc. | 2018-07-17 |
| Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus (NCT03758079) | University of Balamand | 2018-06-01 |
| Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients (NCT03576235) | Seoul National University Boramae Hospital | 2018-05-01 |
| A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1) (NCT03422653) | Cara Therapeutics, Inc. | 2018-02-20 |
| Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (NCT03281538) | Cara Therapeutics, Inc. | 2017-08-14 |
| TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus (NCT03002233) | Toray Industries, Inc | 2016-11-01 |
| Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (NCT02858726) | Cara Therapeutics, Inc. | 2016-06-01 |
| Treatment of Uremic Pruritus With PA101B (NCT02696499) | Patara Pharma | 2016-02-01 |
| Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus (NCT02229929) | Cara Therapeutics, Inc. | 2014-07-01 |
| Pregabalin for the Treatment of Uremic Pruritus (NCT01852318) | National Taiwan University Hospital | 2014-04-01 |
| Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus (NCT02373215) | Trevi Therapeutics | 2013-04-01 |
| Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis (NCT01660243) | Toray Industries, Inc | 2012-09-01 |
| Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus (NCT01073501) | Shaare Zedek Medical Center | 2010-04-01 |
| A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch) (NCT00793156) | Acologix, Inc. | 2009-12-01 |
| The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney Disease (NCT00494975) | National Taiwan University Hospital | 2007-06-01 |
| Treatment of Uremic Pruritus by Olive-omega 3 Ointment (NCT01447693) | Assaf-Harofeh Medical Center | |